共 50 条
[1]
A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers
[J].
European Journal of Clinical Pharmacology,
2018, 74
:69-77
[3]
Phase 1 Dose-Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
[J].
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT,
2020, 9 (01)
:11-20
[4]
Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers
[J].
FRONTIERS IN PHARMACOLOGY,
2019, 10
[9]
Safety and Pharmacokinetics of Olokizumab, an Anti-IL-6 Monoclonal Antibody, Administered to Healthy Male Volunteers: A Randomized Phase I Study
[J].
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT,
2014, 3 (05)
:388-395